Most Active Stories
- Plan To Make 6 States Out Of California May Head To Ballot
- Protesters Dispute Possible Immigration Reform Outside Mexican Consulate
- New Little Rock Police Chief Aims To Restore Trust In Law Enforcement
- Christie and Romney Visiting Arkansas: How Much Of It Is For Hutchinson?
- David Pryor Stumping For His Son In North Little Rock
Local & Regional News
Wed May 15, 2013
Arkansas Correction Agency Loses Drug Company Account
The Arkansas Department of Correction says a pharmaceutical company has closed its account after the state last month acknowledged plans to use its anti-seizure drug phenobarbital in executions.
Department of Correction spokeswoman Shea Wilson told The Associated Press that West-Ward Pharmaceuticals officials notified the agency Wednesday that the company was closing the prison system's account.
The agency said last month that it would use phenobarbital in executions, even though the barbiturate has never been used in U.S. lethal injections.
West-Ward's London-based parent company, Hikma Pharmaceuticals, said Wednesday that it objects to its products' use in capital punishment.
Hikma also said it would no longer sell injectable phenobarbital directly to U.S. corrections departments.
However, Hikma spokesman Matthew Cole would not discuss specifics about Arkansas' account. Arkansas doesn't have any pending executions.